Outlook Therapeutics (OTLK) Preferred Dividend Payments (2015 - 2019)
Outlook Therapeutics (OTLK) reported Preferred Dividend Payments of $166133.0 for Q4 2019, up 10.38% year-over-year from $150508.0 in Q4 2018, and up 2.5% quarter-over-quarter from $162081.0 in Q3 2019.
Outlook Therapeutics (OTLK) Preferred Dividend Payments (2015 - 2019) Analysis & Trends
Outlook Therapeutics (OTLK) has 5 years of Preferred Dividend Payments data on file, last reported at $166133.0 in Q4 2019.
- Preferred Dividend Payments for Q4 2019 came in at $166133.0, up 10.38% year-over-year; the trailing twelve-month figure through Sep 2020 was $166133.0 (down 73.42% YoY), and the FY2020 annual result was $166133.0, down 73.42% from the prior year.
- Preferred Dividend Payments grew to $166133.0 in Q4 2019 per OTLK's latest filing, from $162081.0 in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $1.1 million in Q3 2015 and troughed at $150508.0 in Q4 2018.
- A 5-year average of $559569.0 and a median of $493207.0 in 2016 frame the typical range for Preferred Dividend Payments.
- On a YoY basis, Preferred Dividend Payments climbed as much as 10.38% in 2019 and fell as far as 75.77% in 2019.
- A 5-year view of Preferred Dividend Payments shows it stood at $939539.0 in 2015, then tumbled by 47.51% to $493207.0 in 2016, then fell by 8.6% to $450801.0 in 2017, then slumped by 66.61% to $150508.0 in 2018, then climbed by 10.38% to $166133.0 in 2019.
- Business Quant data shows OTLK's Preferred Dividend Payments at $166133.0 in Q4 2019, $162081.0 in Q3 2019, and $158128.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Outlook Therapeutics | 51.56 Mn | 43.81 Mn | -21,888.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 166,133.00 |
| Sep 30, 2019 | 162,081.00 |
| Jun 30, 2019 | 158,128.00 |
| Mar 31, 2019 | 154,271.00 |
| Dec 31, 2018 | 150,508.00 |
| Sep 30, 2018 | 163,822.00 |
| Jun 30, 2018 | 652,612.00 |
| Mar 31, 2018 | 636,695.00 |
| Dec 31, 2017 | 450,801.00 |
| Jun 30, 2016 | 493,207.00 |
| Mar 31, 2016 | 1.03 Mn |
| Dec 31, 2015 | 939,539.00 |
| Sep 30, 2015 | 1.11 Mn |
| Jun 30, 2015 | 1.09 Mn |
| Mar 31, 2015 | 1.03 Mn |